SC 13G/A
Amended Statement of Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001193125-21-041806
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| BB Biotech AG | 3,970,000 | 2.9% |
| Biotech Target N.V. N/A | 3,970,000 | 2.9% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2021-02-12 SC 13G/A · BB Biotech AG 2.9%
- 2020-02-14 SC 13G/A · BB Biotech AG 5.4%
- 2019-02-13 SC 13G/A · BB Biotech AG 5.8%
- 2018-02-14 SC 13G/A · BB Biotech AG 6.0%
- 2017-02-14 SC 13G/A · BB Biotech AG 5.9%
- 2016-02-09 SC 13G/A · BB Biotech AG 5.5%
- 2015-02-13 SC 13G/A · BB Biotech AG 5.4%
- 2014-08-07 SC 13G · BB Biotech AG 5.0%
- 2014-02-12 SC 13G/A · BB Biotech AG 4.1%
- 2013-08-14 SC 13G · BB Biotech AG 5.1%
Loading d134452dsc13ga.htm…